# EDGAR Filing Document

**Accession Number:** 0001650696
**File Stem:** 0001437749-26-001135
**Filing Date:** 2026-1
**Character Count:** 14469
**Document Hash:** 5ba111df1a9e4d31fdba18285c0b853b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-26-001135.hdr.sgml**: 20260113

**ACCESSION NUMBER**: 0001437749-26-001135

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 42

**CONFORMED PERIOD OF REPORT**: 20260113

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260113

**DATE AS OF CHANGE**: 20260113

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Laird Superfood, Inc.
- **CENTRAL INDEX KEY:** 0001650696
- **STANDARD INDUSTRIAL CLASSIFICATION:** FOOD & KINDRED PRODUCTS [2000]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 811589788
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39537
- **FILM NUMBER:** 26528382

**BUSINESS ADDRESS:**
- **STREET 1:** 5303 SPINE ROAD
- **STREET 2:** SUITE 204
- **CITY:** BOULDER
- **STATE:** CO
- **ZIP:** 80301
- **BUSINESS PHONE:** (541) 548-0577

**MAIL ADDRESS:**
- **STREET 1:** 5303 SPINE ROAD
- **STREET 2:** SUITE 204
- **CITY:** BOULDER
- **STATE:** CO
- **ZIP:** 80301

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Laird Superfood, LLC
- **DATE OF NAME CHANGE:** 20150811

?xml version='1.0' encoding='ASCII'? lsf20260112_8k.htm

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): January 13, 2026**

**Laird Superfood, Inc.**

**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Nevada** | **1-39537** | **81-1589788** |
| **(State or other jurisdiction of incorporation)** | **(Commission File Number)** | **(IRS Employer Identification No.)** |

---

---

| | |
|:---|:---|
| **5303 Spine Road, Suite 204, Boulder, Colorado** | **80301** |
| **(Address of principal executive offices)** | **(Zip Code)** |

---

**Registrant**'**s telephone number, including area code: (541) 588-3600**

------

**(Former name or former address, if changed since last report)**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol** | **Name of each exchange on which registered** |
| **Common Stock, $0.001 par value** | **LSF** | **NYSE American** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 7.01**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Regulation FD Disclosure.**

Laird Superfood, Inc. (the "***Company***") is furnishing a copy of an investor presentation (the "***Presentation***") that the Company intends to use, in whole or in part, during the Company's presentation at the 2026 ICR Conference in Orlando, Florida on January 13, 2026. A copy of the Presentation is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

The information contained in the Presentation, including information about the proposed Nexus Investment and the Navitas Acquisition (each as defined below), is summary information that is intended to be considered in the context of the Company's filings with the Securities and Exchange Commission (the "***SEC***") and other public announcements that the Company may make, by press release or otherwise, from time to time. The Company undertakes no duty or obligation to publicly update or revise the information contained in the Presentation, although it may do so from time to time as its management believes is warranted.

The information in this Current Report on Form 8-K is being furnished pursuant to Item 7.01 (including Exhibit 99.1) and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "***Exchange Act***"), or otherwise be subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended (the "***Securities Act***"), or the Exchange Act, whether made before or after the date hereof and regardless of any general incorporation language in such filing.

***Additional Information and Where to Find It***

In connection with the Preferred Stock Issuance (defined below), the Company intends to file preliminary and definitive proxy statements and other materials with the SEC. In addition, the Company may also file other relevant documents with the SEC regarding the proposed Navitas Acquisition and the Nexus Investment (collectively, the "***Transactions***"). **INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE PROXY STATEMENT WHEN IT BECOMES AVAILABLE AND ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTIONS**. The definitive proxy statement and other relevant documents will be sent or given to the Company's stockholders as of the record date established for voting. Investors and stockholders may also obtain a free copy of the proxy statement (when available) and other documents filed by the Company at its website, www.lairdsuperfood.com, or at the SEC's website, www.sec.gov. The proxy statement and other relevant documents may also be obtained for free from the Company by directing such request to the Company, to the attention of Investor Relations, 5303 Spine Road, Suite 204, Boulder, Colorado 80301.

***Participants in the Solicitation***

The Company, Nexus Capital Management, LP ("***Nexus***") and their respective directors, partners and executive officers may be deemed to be participants in the solicitation of proxies from the Company's stockholders in connection with the proposed Transactions. Investors and stockholders may obtain more detailed information regarding the names, affiliations and interests of the Company's directors and executive officers by reading the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, which was filed with the SEC on February 26, 2025. To the extent holdings of shares of common stock by the Company's directors and executive officers have changed from the amounts of shares of common stock held by such persons as reflected in the Company's Annual Report on Form 10-K, such changes have been or will be reflected on Statements of Change in Ownership on Form 4 filed with the SEC. Additional information regarding potential participants in such proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, will be included in the proxy statement and other relevant materials filed with the SEC in connection with the proposed Transactions when they become available.

------

***Forward-Looking Statements***

Certain statements contained in the Presentation constitute "forward-looking statements" as defined in Section 27A of the Securities Act and Section 21E of the Exchange Act that are based on current expectations, estimates, forecasts and assumptions and are subject to risks and uncertainties. Words such as "anticipate," "assume," "began," "believe," "budget," "continue," "could," "estimate," "expect," "forecast," "goal," "intend," "may," "plan," "potential," "predict," "project," "seek," "should," "target," "would" and variations of such words and similar expressions are intended to identify such forward-looking statements. Investors are cautioned that any such statements are not guarantees of future performance and that actual results or developments may differ materially from those projected in the forward-looking statements. Forward-looking statements in the Presentation may include, but are not limited to, statements relating to (i) the proposed Transactions and their expected terms, timing and closing, including receipt of required approvals, satisfaction of other customary closing conditions and expected changes and appointments to the Company's board of directors, (ii) estimates of future synergies, growth opportunities, savings and efficiencies, (iii) expectations regarding the Company's ability to effectively integrate assets and properties it may acquire as a result of the proposed acquisition of Navitas LLC (the "***Navitas Acquisition***"), (iv) expectations of the continued listing of the Company's common stock on the NYSE American LLC and (v) expectations of future plans, priorities, focus and benefits of the proposed Transactions.

Such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of the Company, including but not limited to (i) the ability of the parties to consummate the proposed Transactions in a timely manner or at all, (ii) satisfaction of the conditions precedent to consummation of the private placement of Series A Preferred Stock to Nexus (the "***Preferred Stock Issuance***" and such transaction with Nexus, the "***Nexus Investment***") and the Navitas Acquisition, including the ability to secure required consents and regulatory approvals in a timely manner or at all, and approval by the Company's stockholders of the Preferred Stock Issuance, (iii) the possibility of litigation (including related to the proposed Transactions) and other risks described in the Company's SEC filings. The Company does not undertake and expressly disclaims any obligation to update the forward-looking statements as a result of new information, future events or otherwise, except as required by applicable securities laws. All forward-looking statements are based on management's estimates, projections and assumptions as of the date hereof. More information on potential factors that could affect the Company's financial results will be included in the preliminary and the definitive proxy statements that the Company intends to file with the SEC in connection with the Company's solicitation of proxies for the Company's special meeting of stockholders to be held to approve, among other things, the Preferred Stock Issuance in connection with the proposed Transactions.

***No Offer or Solicitation***

This Current Report on Form 8-K is not a proxy statement or solicitation of a proxy, consent, or authorization with respect to any securities or in respect of the potential Transactions and shall not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of any securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.

**Item 9.01**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Financial Statements and Exhibits.** 

**(d) Exhibits** 

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 99.1 | [Investor Presentation (furnished pursuant to Item 7.01)](ex_906888.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| Date: January 13, 2026 | Laird Superfood, Inc. | Laird Superfood, Inc. |
|  | By: | /s/ Anya Hamill |
|  | Name: | Anya Hamill |
|  | Title: | Chief Financial Officer |

---

## Exhibit 99.1

**Exhibit 99.1**

![lsf_icrpresentationpage01.jpg](lsf_icrpresentationpage01.jpg)

------

![lsf_icrpresentationpage02.jpg](lsf_icrpresentationpage02.jpg)

------

![lsf_icrpresentationpage03.jpg](lsf_icrpresentationpage03.jpg)

------

![lsf_icrpresentationpage04.jpg](lsf_icrpresentationpage04.jpg)

------

![lsf_icrpresentationpage05.jpg](lsf_icrpresentationpage05.jpg)

------

![lsf_icrpresentationpage06.jpg](lsf_icrpresentationpage06.jpg)

------

![lsf_icrpresentationpage07.jpg](lsf_icrpresentationpage07.jpg)

------

![lsf_icrpresentationpage08.jpg](lsf_icrpresentationpage08.jpg)

------

![lsf_icrpresentationpage09.jpg](lsf_icrpresentationpage09.jpg)

------

![lsf_icrpresentationpage10.jpg](lsf_icrpresentationpage10.jpg)

------

![lsf_icrpresentationpage11.jpg](lsf_icrpresentationpage11.jpg)

------

![lsf_icrpresentationpage12.jpg](lsf_icrpresentationpage12.jpg)

------

![lsf_icrpresentationpage13.jpg](lsf_icrpresentationpage13.jpg)

------

![lsf_icrpresentationpage14.jpg](lsf_icrpresentationpage14.jpg)

------

![lsf_icrpresentationpage15.jpg](lsf_icrpresentationpage15.jpg)

------

![lsf_icrpresentationpage16.jpg](lsf_icrpresentationpage16.jpg)

------

![lsf_icrpresentationpage17.jpg](lsf_icrpresentationpage17.jpg)

------

![lsf_icrpresentationpage18.jpg](lsf_icrpresentationpage18.jpg)

------

![lsf_icrpresentationpage19.jpg](lsf_icrpresentationpage19.jpg)

------

![lsf_icrpresentationpage20.jpg](lsf_icrpresentationpage20.jpg)

------

![lsf_icrpresentationpage21.jpg](lsf_icrpresentationpage21.jpg)

------

![lsf_icrpresentationpage22.jpg](lsf_icrpresentationpage22.jpg)

------

![lsf_icrpresentationpage23.jpg](lsf_icrpresentationpage23.jpg)

------

![lsf_icrpresentationpage24.jpg](lsf_icrpresentationpage24.jpg)

------

![lsf_icrpresentationpage25.jpg](lsf_icrpresentationpage25.jpg)

------

![lsf_icrpresentationpage26.jpg](lsf_icrpresentationpage26.jpg)

------

![lsf_icrpresentationpage27.jpg](lsf_icrpresentationpage27.jpg)

------

![i28.jpg](i28.jpg)